The Marketplace
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories | Feb 19, 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories | Feb 15, 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research<br><br>Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research<br><br>Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research<br><br>
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research

Andrew Alliance | Feb 14, 2019
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.

Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
CORNING INCORPORATED | Feb 13, 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
CORNING INCORPORATED | Feb 13, 2019
High-throughput spheroid microplate benefits cancer research, drug screening
How to tango with DMSO &ndash; A smart way to evaporate tough solvents
How to tango with DMSO – A smart way to evaporate tough solvents
BioChromato | Feb 13, 2019
When it comes to organic synthesis, drug discovery, or natural products/polymer chemistry, one of the trickiest but most ubiquitous steps in the workflow is evaporation. For many years, chemists have struggled with the task of rapidly and efficiently evaporating solvents that have high boiling points – think DMF or DMSO. The standard rotary evaporator in the lab is not ideal for getting rid of these solvents; it is painstakingly slow in such cases, must be closely monitored, and can easily bump.
Norgen Biotek&#39;s Cell-free DNA / Cell-free RNA (cf-DNA/cf-RNA) BCT Tube is Best-In-Class
Norgen Biotek's Cell-free DNA / Cell-free RNA (cf-DNA/cf-RNA) BCT Tube is Best-In-Class
Norgen Biotek Corp. | Feb 12, 2019
Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acid and protein stabilization and purification, today announced their unique cf-DNA/cf-RNA Preservative Tubes were found to be the most suitable for liquid biopsy when compared to other leading competitor's blood collection tubes (BCTs)
Lonza&rsquo;s New Pooled Donor Suspension Hepatocytes Enable the Next Level of Reliability, Robustness and Customizability
Lonza’s New Pooled Donor Suspension Hepatocytes Enable the Next Level of Reliability, Robustness and Customizability
Lonza | Feb 11, 2019
Lonza announces the launch of DonorPlex™ Hepatocytes, a new line of high-quality cryopreserved pooled donor suspension hepatocytes, which are the first of their kind to be produced using Lonza’s novel patented manufacturing process. Researchers within DMPK and ADME laboratories can now benefit from this reliable and robust product offering for studying the hepatic metabolism of drugs.
Explore Cells from the Inside Out
Explore Cells from the Inside Out
The Scientist Creative Services Team | Feb 11, 2019
Download this eBook from Molecular Devices to learn about the wide variety of applications used in modern cell biology!
Lonza and AllCells Join Forces for Global Commercialization of Hematopoietic Primary Cells
Lonza and AllCells Join Forces for Global Commercialization of Hematopoietic Primary Cells
Lonza | Feb 8, 2019
Lonza and AllCells have entered into a private label partnership for the manufacture and global commercialization of an extensive range of hematopoietic primary cells. This partnership expands Lonza’s broad offering of hematopoietic cell lines and enables cell biologists to easily access a wide selection of high-quality cells to boost their scientific research.